4//SEC Filing
Patel Naimish 4
Accession 0000950170-24-115697
CIK 0001674416other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 5:35 PM ET
Size
5.3 KB
Accession
0000950170-24-115697
Insider Transaction Report
Form 4
Patel Naimish
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-16+18,333→ 18,333 totalExercise: $49.00Exp: 2034-10-16→ Common Shares (18,333 underlying)
Footnotes (1)
- [F1]This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 16, 2024.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0002021679
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 5:35 PM ET
- Size
- 5.3 KB